The Evolution of Patient Centricity in Pharma (Pre-2020 to 2025): From Aspiration to Embedded Reality
Patient centricity: A defining imperative in healthcare As patient expectations evolve and regulatory bodies demand greater transparency, the pharmaceutical industry is undergoing a profound transformation in terms of patient centricity. Our latest white paper, “The Evolution of Patient Centricity in Pharma (Pre-2020 to 2025): From Aspiration to Embedded Reality,” explores how patient centricity has shifted from…...
Read MoreTop Stories
What’s Next for Global Capability Centers )?
The theme for this year’s NASSCOM GCC Summit, “The Next GCC...
MAPS 2025 Decoded: The Medical Affairs Playbook
At the MAPS Americas 2025 conference in New Orleans, one of...
Medical Affairs 2.0: GenAI as the Catalyst for
Digital and AI were hot topics underpinning many of the...
Filter
Knowledge Exchange in a New Virtual World: How the Pandemic Redefined MSL-HCP Interactions
The pandemic threw a curve ball at MSL-HCP relationships, which have traditionally relied on face-to-face...
5 Tips to Ace Your Next Virtual Conference Presentation
This video offers you 5 easy tips for presenting your research at a virtual conference...
Publication Planning Training for Regional Medical Affairs Team
How a global pharma company overcame challenges of integration with regional teams in terms of...
US FDA (Food And Drug Administration) Social Medial Usage Guidelines: Compliance for Pharma Companies
This poster presents results of an analysis of trends in adherence of pharmaceutical companies to...
The Battle for Evidence-Based Truth in a War of Misinformation
I was talking to someone I know — let’s call her Joanna — about the...